S. Vora

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

V. Calvez, H. Günthard, S. Yerly, 2006, AIDS.

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance

J P Bru, A. Telenti, M. Battegay, 2001, AIDS.

Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection

T. Perneger, S. Yerly, L. Perrin, 2000, AIDS.

Treatment and Prognosis of AIDS-Related Lymphoma in the Era of Highly Active Antiretroviral Therapy: Findings from the Swiss HIV Cohort Study

M. Battegay, H. Furrer, P. Vernazza, 2007, Antiviral therapy.

Pancreatic stone protein as a biomarker for the early diagnosis of post-operative peritonitis, intra-abdominal infection and sepsis

D. Pugin, Y. Gasche, Frédéric Mollard, 2022, Journal of surgical case reports.

Switch from indinavir to ritonavir-indinavir regimen in patients treated with highly active antiretroviral therapy co-infected with hepatitis C is not associated with alteration of liver function tests.

S. Yerly, C. Michon, L. Perrin, 2000, AIDS.

CCR5 Genotyping and Chemokine Receptor usage among HIV-1 Treatment - Naive and Experienced Patients in India

Das Br, S. Mukherjee, S. Vora, 2015 .

Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age.

P. Vanhems, L. Perrin, B. Hirschel, 2002, Journal of acquired immune deficiency syndromes.